Medicilon was awarded “2019 Excellent Listed Enterprise” for its remarkable innovation and advances in the year 2019, at ZJ Science City Annual Event in Jan. 10th, 2020. This award showcased the huge progress Medicilon has made since going public in 2019 and would inspire Medicilon to keep the momentum in 2020 and achieve bigger success.
ZJ Science City supported Medicilon by training technical talents, building integrated industrial chains and offering extra assistance to biopharma industry throughout the development of Medicilon. Medicilon now has grown into one of the leading CRO in China with a total lab area of over 323,000 sqft. Medicilon has already worked with more than 500 clients worldwide on their scientific research and looks forward to assisting more companies, research facilities worldwide and striving for the success of new drug development!